4-Step Convergent Synthesis of PN6047 HCl via Sequential Suzuki Coupling

Commercial-scale manufacture of promising drug candidates frequently stalls not because the chemistry is impossible, but because the existing synthesis route was designed for discovery rather than production. PN6047 HCl, a promising analgesic compound, faced three interconnected barriers to commercial viability: low yields, a cost-prohibitive coupling reagent, and an environmentally burdensome solvent pathway — each addressable in isolation, but requiring a fundamentally different route architecture to eliminate simultaneously.

CCG developed a convergent 4-step alternative synthesis that resolves all three barriers in a single redesign. The route replaces HATU-dependent amide chemistry with pre-amidated boronic acid coupling partners, substitutes direct N-alkylation for reductive amination, and delivers a fully Class 3 solvent pathway throughout — built entirely from commodity starting materials with confirmed multi-supplier tonne-scale availability and projected cost of goods competitive with the challenge target.

Relevant consulting applications:

• Synthesis route assessment and redesign for pharmaceutical compounds approaching scale-up

• Cost-of-goods analysis and manufacturing feasibility for drug development programs

• Regulatory chemistry strategy including solvent classification and green chemistry compliance

• Cross-domain problem framing for chemistry teams where incremental optimization of an existing route has reached a ceiling